These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35850434)

  • 1. Statins and angiogenesis in non-cardiovascular diseases.
    Zahedipour F; Butler AE; Rizzo M; Sahebkar A
    Drug Discov Today; 2022 Oct; 27(10):103320. PubMed ID: 35850434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic properties of statins via angiogenesis modulation in cardiovascular disease.
    Zahedipour F; Butler AE; Eid AH; Sahebkar A
    Drug Discov Today; 2022 Oct; 27(10):103325. PubMed ID: 35872297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse effects of statins on angiogenesis: new therapeutic avenues.
    Elewa HF; El-Remessy AB; Somanath PR; Fagan SC
    Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HMG-CoA reductase pathway, statins and angioprevention.
    Feng C; Han A; Ye C; Xu R; Li M
    Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
    Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
    Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statin therapy on the progression of chronic kidney disease.
    Shah S; Paparello J; Danesh FR
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium.
    Chłopicki S; Gryglewski RJ
    Pharmacol Rep; 2005; 57 Suppl():86-96. PubMed ID: 16415489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?
    Balakumar P; Mahadevan N
    Br J Pharmacol; 2012 Jan; 165(2):373-9. PubMed ID: 21790534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy in cardiovascular diseases other than atherosclerosis.
    Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
    Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
    J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins as potential therapeutic agents in multiple sclerosis.
    Stüve O; Prod'homme T; Youssef S; Dunn S; Neuhaus O; Weber M; Hartung HP; Steinman L; Zamvil SS
    Curr Neurol Neurosci Rep; 2004 May; 4(3):237-44. PubMed ID: 15102350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anticancer properties of statins].
    Sławińska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and cancer.
    Vallianou NG; Kostantinou A; Kougias M; Kazazis C
    Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.